about
Neuromuscular Junction Formation in Tissue-Engineered Skeletal Muscle Augments Contractile Function and Improves Cytoskeletal Organization.Exercise duration-matched interval and continuous sprint cycling induce similar increases in AMPK phosphorylation, PGC-1α and VEGF mRNA expression in trained individuals.Creating Interactions between Tissue-Engineered Skeletal Muscle and the Peripheral Nervous System.Defining the Balance between Regeneration and Pathological Ossification in Skeletal Muscle Following Traumatic Injury.Stretching skeletal muscle in vitro: does it replicate in vivo physiology?Mimicking exercise in three-dimensional bioengineered skeletal muscle to investigate cellular and molecular mechanisms of physiological adaptation.Leucine elicits myotube hypertrophy and enhances maximal contractile force in tissue engineered skeletal muscle in vitro.Hypoxia Impairs Muscle Function and Reduces Myotube Size in Tissue Engineered Skeletal MuscleAcute mechanical overload increases IGF-I and MMP-9 mRNA in 3D tissue-engineered skeletal muscle.Modelling in vivo skeletal muscle ageing in vitro using three-dimensional bioengineered constructs.The effect of chronic high insulin exposure upon metabolic and myogenic markers in C2C12 skeletal muscle cells and myotubes.The acute angiogenic signalling response to low-load resistance exercise with blood flow restriction.Factors affecting the structure and maturation of human tissue engineered skeletal muscle.Resolvin E1 (Rv E1 ) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes.An Assessment of Myotube Morphology, Matrix Deformation, and Myogenic mRNA Expression in Custom-Built and Commercially Available Engineered Muscle Chamber Configurations.Critical power is positively related to skeletal muscle capillarity and type I muscle fibers in endurance-trained individualsResistance exercise stimulates mixed muscle protein synthesis in lean and obese young adultsMechanical loading stimulates hypertrophy in tissue-engineered skeletal muscle: Molecular and phenotypic responses
P50
Q36160903-D2BB1D57-E49F-4127-9C54-1F72804253C5Q37092687-3F08AF99-BD6D-43C7-A3C2-70EC5EAAC119Q37522846-4BEA0712-ACEC-40E0-B189-6E772ABF9B07Q37733728-1AB8A49C-6D0A-465C-B97E-7A2DAFC66CD7Q37863056-52BDF762-B4AA-424F-90BD-CD8BCF0B5E94Q38761926-2C86780A-404F-4433-84E0-C3ED8643175EQ38836988-F9A9431F-C4A1-47CC-9711-0C811D34D20EQ38907518-864A3985-26CB-4640-B23F-F7EBCBBDFDF6Q39021536-0C001A99-82B4-42E1-836A-084E53115C27Q39571282-D077CC5C-D0DD-4B33-9BBF-28E01F64862FQ49562862-1BA49363-C4C5-4DCA-9F8D-25FD681929FCQ49994164-88E367E9-26E4-4561-84E7-E25B9D3F8531Q51020505-3CEF026E-6896-4C8A-8D28-A8F1211F4637Q51735345-4A78FC60-E74C-4922-A8BB-49866ED2C301Q55193920-2B49034C-9227-4C3F-AEBB-4C2B3EB3435CQ89024750-4E05A1E8-8F92-49CF-8B74-1CA1A9FA4D04Q90227114-F9B5FE4B-0825-4763-BBA5-BAAEB3E57288Q92628963-85AA619C-7C2F-4ED4-B2A9-07AE6B9B836C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Neil Martin
@ast
Neil Martin
@en
Neil Martin
@es
Neil Martin
@nl
type
label
Neil Martin
@ast
Neil Martin
@en
Neil Martin
@es
Neil Martin
@nl
prefLabel
Neil Martin
@ast
Neil Martin
@en
Neil Martin
@es
Neil Martin
@nl
P106
P1153
57191998348
P31
P496
0000-0002-1988-047X